We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH to Test Three Immune Modulators to Treat COVID-19 Cytokine Storm
NIH to Test Three Immune Modulators to Treat COVID-19 Cytokine Storm
The National Institutes of Health (NIH) is starting a late-stage trial of two existing drugs and one investigational agent to assess their potential to control cytokine storm, an immune system overreaction in COVID-19 patients.